FIELD: chemistry.
SUBSTANCE: invention relates to use of 2-(1,1-dimethyl-1H-benzo[e]indolin-2-yl)-5,6,7-trichloro-1,3-tropolone of formula (1) as an agent having cytotoxic activity with respect to U87MG glioma cell culture.
EFFECT: higher cytotoxic activity with respect to U87MG glioma cell culture.
2 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
2-(1,1-DIMETHYL-1H-BENZO[E]INDOLIN-2-YL)-5,6,7-TRICHLORO-1,3-TROPOLONE, WHICH HAS CYTOTOXIC ACTIVITY AGAINST A431 SKIN CANCER AND H1299 LUNG CANCER CELL CULTURES | 2023 |
|
RU2810581C1 |
AGENT HAVING CYTOTOXIC ACTIVITY ON NON-SMALL-CELL LUNG CANCER CELL CULTURE A 549 | 2020 |
|
RU2741311C1 |
5,7-DI(TERT-BUTYL)-2-(4,7-DICHLORO-8-METHYL-5-NITROQUINOLIN-2-YL)-4-NITRO-1,3-TROPOLONE, HAVING CYTOTOXIC ACTIVITY | 2019 |
|
RU2702648C1 |
1,1'-(HEXANE-1,6-DIYL)BIS(3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTAREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES TEMOZOLOMIDE ACTIVITY ON GLIOBLASTOMA CELLS | 2019 |
|
RU2724882C1 |
USE OF 10-(4-PHENYL-5-CYANO-1H-1,2,3-TRIAZOL-1-YL)PYRIDO[1,2-a]INDOLE AS SELECTIVE INHIBITOR OF MALIGNANT CELL ACTIVITY | 2023 |
|
RU2828079C1 |
DERIVATIVES OF IMIDAZOLIDINE-2,4-DIONE AND IMIDAZOLIDINE-2,4,5-TRIONE BASED ON RESIN ACIDS, EXHIBITING ANTI-INVASIVE ACTIVITY ON GLIOBLASTOMA CELLS OF T98G AND SNB-19 LINES | 2023 |
|
RU2821104C1 |
N-(2-(2-(2-AZIDOETHOXY)ETHOXY)ETHYL)-4,6-DI(AZIRIDIN-1-YL)-1,3,5-TRIAZIN-2-AMINE, HAVING CYTOTOXIC ACTION | 2023 |
|
RU2825828C1 |
1-ADAMANTYL-3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES ACTIVITY OF TEMOZOLOMIDE AGAINST GLIOBLASTOMA CELLS | 2019 |
|
RU2697409C1 |
METHYL 6-[(4-(AZIRIDIN-1-YL)-6-CHLORO-1,3,5-TRIAZIN-2-YL)AMINO]HEXANOATE, WHICH HAS A CYTOTOXIC EFFECT | 2022 |
|
RU2791798C1 |
CELL LINE OF RAT GLIOMA C6-DDA RESISTANT TO CYTOTOXIC ACTION OF N-ACYL DOPAMINE, FOR STUDYING MECHANISMS OF BIOACTIVE LIPIDS ACTION | 2017 |
|
RU2694868C2 |
Authors
Dates
2025-05-13—Published
2024-07-15—Filed